Previous 10 | Next 10 |
2023-08-03 14:26:08 ET Shares of Inari Medical (NASDAQ: NARI) were up by more than 21% as of 1:45 p.m. on Thursday after the company reported second-quarter results after the markets closed Wednesday. The healthcare stock is up more than 5% so far this year. Inari is a medic...
2023-08-02 22:10:04 ET Inari Medical, Inc. (NARI) Q2 2023 Earnings Call Transcript August 02, 2023 04:30 PM ET Company Participants John Hsu - Vice President of Investor Relations Drew Hykes - President and CEO Mitch Hill - CFO Tom Tu - Chief Medical Officer ...
2023-08-02 16:25:15 ET Inari Medical press release ( NASDAQ: NARI ): Q2 GAAP EPS of $0.04 beats by $0.16 . Revenue of $119M (+28.4% Y/Y) beats by $2.28M . For the full year 2023, we are raising our revenue guidance to a range of $482 million to $492 m...
IRVINE, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its second quarter ende...
2023-08-01 17:35:57 ET Inari Medical ( NASDAQ: NARI ) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, after market close. The consensus EPS Estimate is -$0.12 and the consensus Revenue Estimate is $116.72M (+25.9% Y/Y). Over the last 3 months, EP...
2023-07-31 06:06:55 ET Summary Shares of Inari Medical have been lagging after seeing strong momentum post its IPO in 2020. The reversal of the share price looks interesting as topline growth has continued, albeit margins have taken a beating here. While current and modest los...
IRVINE, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present at the...
IRVINE, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its second quarter 2023...
2023-06-14 16:42:19 ET Summary AngioDynamics and Merit Medical came together for a $100M transaction that will transfer ANGO's hemodialysis and BioSentry products to Merit. Merit is gaining more scale and adding specialty products in an already-important dialysis business, and thi...
IRVINE, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced the launch of two new purpose-built products, the R...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
SAN FRANCISCO, June 27, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...